Zejula - Keytruda Combination Therapy in TNBC
Newsletter Signup | Join Community | Cancer Types
Checkpoint inhibitors active in TNBC with PD-L1 expression.
Trilaciclib chemotherapy combination encouraging inTNBC - FDA registration trial to begin.
Keytruda, Tecentriq, and Sacituzumab Govitecan (IMMU-132) are promising TNBC treatment advances.
The role of surgery in the management of TNBC.
Capivasertib precison cancer medicine is active in the treatment of women with TNBC & PIK3CA, AKT1 and/or PTEN mutations
Dr. Bhuvaneswari Ramaswamy of the OSU Arthur G. James Cancer Hospital answers frequently asked questions about TNBC
Stay Current With Triple-Negative Breast Cancer Treatment Advances & Connect with Others
Iniparib Promising in Metastatic Triple-negative Breast Cancer
Is anyones doctor recommending treatment with a checkpoint inhibitor? These seem like they…
Interesting data published this week show HDC appears to benefit TNBC: https://mavendoctors…